These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29406467)

  • 1. Subtype-specific Clinical Presentation, Medical Treatment and Family Impact of Influenza in Children 1-5 Years of Age Treated in Outpatient Practices in Germany During Three Postpandemic Years, 2013-2015.
    Streng A; Prifert C; Weissbrich B; Sauerbrei A; Schmidt-Ott R; Liese JG
    Pediatr Infect Dis J; 2018 Sep; 37(9):861-867. PubMed ID: 29406467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza Virus Subtyping by Multiplex PCR during Winter Months of 2017-2018.
    Noor M; Niazi SUK; Tayyab N; Gardezi SA; Ghani E; Khadim MT
    J Coll Physicians Surg Pak; 2019 May; 29(5):459-462. PubMed ID: 31036119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued high incidence of children with severe influenza A(H1N1)pdm09 admitted to paediatric intensive care units in Germany during the first three post-pandemic influenza seasons, 2010/11-2012/13.
    Streng A; Prifert C; Weissbrich B; Liese JG;
    BMC Infect Dis; 2015 Dec; 15():573. PubMed ID: 26678835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Prescription Practices Among Children with Influenza.
    Nitsch-Osuch A; Gyrczuk E; Wardyn A; Życinska K; Brydak L
    Adv Exp Med Biol; 2016; 905():25-31. PubMed ID: 26801146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostics of viral respiratory infections in hospitalized patients and ambulatory patients from SENTINEL program during 2004/05 season in Poland].
    Brydak LB; Lietzau G; Machała M
    Pol Arch Med Wewn; 2005 Oct; 114(4):958-67. PubMed ID: 16789521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009.
    Esposito S; Molteni CG; Daleno C; Valzano A; Fossali E; Da Dalt L; Cecinati V; Bruzzese E; Giacchino R; Giaquinto C; Lackenby A; Principi N
    BMC Infect Dis; 2011 Oct; 11():271. PubMed ID: 21992699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2009 pandemic influenza A(H1N1) coincides with changes in the epidemiology of other viral pathogens causing acute respiratory tract infections in children.
    Gröndahl B; Ankermann T; von Bismarck P; Rockahr S; Kowalzik F; Gehring S; Meyer C; Knuf M; Puppe W
    Infection; 2014 Apr; 42(2):303-8. PubMed ID: 24150959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimum timing of oseltamivir: lessons from Bangladesh.
    Ison MG
    Lancet Infect Dis; 2014 Feb; 14(2):88-9. PubMed ID: 24268592
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
    Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Burden of Influenza A/H1N1, A/H3N2 and B Infections in Children Treated as Outpatients.
    Silvennoinen H; Huusko T; Vuorinen T; Heikkinen T
    Pediatr Infect Dis J; 2015 Oct; 34(10):1081-5. PubMed ID: 26181897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza-induced acute respiratory distress syndrome during the 2010-2016 seasons: bacterial co-infections and outcomes by virus type and subtype.
    Bal A; Casalegno JS; Melenotte C; Daviet F; Ninove L; Edouard S; Morfin F; Valette M; De Lamballerie X; Lina B; Papazian L; Nougairède A; Hraiech S
    Clin Microbiol Infect; 2020 Jul; 26(7):947.e1-947.e4. PubMed ID: 32205296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of influenza among hospitalized febrile children in Ghana.
    Hogan B; Ammer L; Zimmermann M; Binger T; Krumkamp R; Sarpong N; Rettig T; Dekker D; Kreuels B; Reigl L; Boahen KG; Wiafe C; Adu-Sarkodie Y; Owusu-Dabo E; May J; Eibach D
    Influenza Other Respir Viruses; 2017 Nov; 11(6):497-501. PubMed ID: 28991406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The 2013-2014 epidemic season. Hospital monitoring and antiviral therapy for influenza ].
    Kolobukhina LV; Burtseva EI; Shelkanov MIu; Al'khovskiĭ SV; Prilipov AG; Merkulova LN; Kisteneva LB; Vartanian RV; Kruzhkova IS; Trushakova SV; Krasnoslobodtsev KG; Avdeev SM; Sutochnikova OA; Bazarova MV; Kelly EI; Ambrosi OE; Malyshev nA; L'vov DK; Chuchalin AG
    Ter Arkh; 2014; 86(10):52-9. PubMed ID: 25509893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses.
    Okada T; Morozumi M; Matsubara K; Komiyama O; Ubukata K; Takahashi T; Iwata S
    J Infect Chemother; 2011 Apr; 17(2):238-45. PubMed ID: 20827563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness of baloxavir marboxil against influenza in three seasons.
    Kakuya F; Okubo H; Fujiyasu H; Kurisawa MJ; Kinebuchi T
    Pediatr Int; 2022 Jan; 64(1):e15169. PubMed ID: 35790049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza A/H1N1 in pediatric oncology patients.
    Dotan A; Ben-Shimol S; Fruchtman Y; Avni-Shemer Y; Kapelushnik J; Ben-Harush M; Givon-Lavi N; Leibovitz E; Greenberg D
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e271-4. PubMed ID: 24136021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar severity of influenza primary and re-infections in pre-school children requiring outpatient treatment due to febrile acute respiratory illness: prospective, multicentre surveillance study (2013-2015).
    Streng A; Prifert C; Weissbrich B; Sauerbrei A; Krumbholz A; Schmidt-Ott R; Liese JG
    BMC Infect Dis; 2022 Jan; 22(1):12. PubMed ID: 34983428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.